Volume 20 Number 7
31 July 2018

Home > Publications > Current Neuro-Oncology > Volume 20, Year 2018 > Number 7, 31 July

Hamamoto Filho PT, Magro IB, Zanini MA.
Behavioural changes caused by diffuse intrinsic pontine glioma.
Rev Assoc Med Bras (1992). 2018 Jul;64(7):581-582. doi: 10.1590/1806-9282.64.07.581. PMID: 30365657. Case report. ˍ

Unterrainer M, Fleischmann DF, Lindner S, Brendel M, Rupprecht R, Tonn JC, Belka C, Bartenstein P, Niyazi M, Albert NL.
Detection of Cerebrospinal Fluid Dissemination of Recurrent Glioblastoma Using TSPO-PET With 18F-GE-180.
Clin Nucl Med. 2018 Jul;43(7):518-519. doi: 10.1097/RLU.0000000000002113. PMID: 29742608. Case report. ˍ

Marinelli A, Lamberti G, Cerbone L, Cordua N, Buonerba C, Peluso G, Di Lorenzo G, De Placido S.
High-dose fotemustine in temozolomide-pretreated glioblastoma multiforme patients: A phase I/II trial.
Medicine (Baltimore). 2018 Jul;97(27):e11254
. doi: 10.1097/MD.0000000000011254. PMID: 29979390. Interventional study. ˍ

Bokun J, Grujicic D, Skender-Gazibara M, Paripovic L, Pekmezovic T, Kisic-Tepavcevic D, Ilic V, Raicevic S, Stanic D, Miskovic I, Saric M, Nikitovic M.
Management and treatment of children with medulloblastoma in Serbia, a middle-income country.
J BUON. 2018 Jul-Aug;23(4):1156-1162. PMID: 30358225. Observational study. ˍ

Cheon YJ, Jung TY, Jung S, Kim IY, Moon KS, Lim SH.
Efficacy of Gamma Knife Radiosurgery for Recurrent High-Grade Gliomas with Limited Tumor Volume.
J Korean Neurosurg Soc. 2018 Jul 1, 2018;61(4):516-524
. doi: 10.3340/jkns.2017.0259. PMID: 29991111. Observational study. ˍ

Esquenazi Y, Moussazadeh N, Link TW, Hovinga KE, Reiner AS, DiStefano NM, Brennan C, Gutin P, Tabar V.
Thalamic Glioblastoma: Clinical Presentation, Management Strategies, and Outcomes.
Neurosurgery. 2018 Jul 1, 2018;83(1):76-85
. doi: 10.1093/neuros/nyx349. PMID: 28973417. Observational study. ˍ

Lassman AB, van den Bent MJ, Gan HK, Reardon DA, Kumthekar P, Butowski N, Lwin Z, Mikkelsen T, Nabors LB, Papadopoulos KP, Penas-Prado M, Simes J, Wheeler H, Walbert T, Scott AM, Gomez E, Lee HJ, Roberts-Rapp L, Xiong H, Ansell PJ, Bain E, Holen KD, Maag D, Merrell R.
Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial.
Neuro Oncol. 2018 Jul 5,
2019;21(1):106-114. doi: 10.1093/neuonc/noy091. PMID: 29982805. Interventional study. ˍ

Singh M, Venugopal C, Tokar T, McFarlane N, Subapanditha MK, Qazi M, Bakhshinyan D, Vora P, Murty N, Jurisica I, Singh SK.
Therapeutic targeting of the pre-metastatic stage in human Lung-to-brain metastasis.
Cancer Res. 2018 Jul 9,
2018;78(17):5124-5134. doi: 10.1158/0008-5472.CAN-18-1022. PMID: 29986997. Laboratory investigation. ˍ

Yamaguchi S, Ishi Y, Motegi H, Okamoto M, Kobayashi H, Hirata K, Oda Y, Tanaka S, Terasaka S, Houkin K.
The prognostic improvement of add-on bevacizumab for progressive disease during concomitant temozolomide and radiation therapy in the patients with glioblastoma and anaplastic astrocytoma.
J Neurosurg Sci. 2018 Jul 9, 2020;64(6):502-508. doi: 10.23736/S0390-5616.18.04463-6. PMID: 30035459. Observational study. ˍ

Li Q, Dai Z, Cao Y, Wang L.
Comparing children and adults with medulloblastoma: a SEER based analysis.
Oncotarget. 2018 Jul 10, 2018;9(53):30189-30198. doi: 10.18632/oncotarget.23773. PMID: 30046397. Observational study. ˍ

Shen CJ, Kummerlowe MN, Redmond KJ, Martinez-Gutierrez JC, Usama SM, Holdhoff M, Grossman SA, Laterra JJ, Strowd RE, Kleinberg LR.
Re-irradiation for malignant glioma: Toward patient selection and defining treatment parameters for salvage.
Adv Radiat Oncol. 2018 Jul 9, 2018;3(4):582-590. doi: 10.1016/j.adro.2018.06.005. PMID: 30370358. Observational study. ˍ

Kristeva M, Suprun A, Ghaffar E, Wallis C.
Adult Medulloblastoma: Occurrence of a Rare Event.
Cureus. 2018 Jul 18, 2018;10(7):e3000. doi: 10.7759/cureus.3000. PMID: 30397563. Case report. ˍ

Jayamanne D, Wheeler H, Brazier D, Newey A, Kastelan M, Guo L, Back M.
Predicting patterns of failure in temporal lobe GBMs: possible implications on radiotherapy treatment portals.
Radiat Oncol. 2018 Jul 20, 2018;13(1):133. doi: 10.1186/s13014-018-1078-y. PMID: 30029668. Observational study. ˍ

Le Rhun E, Genbrugge E, Stupp R, Chinot OL, Nabors LB, Cloughesy T, Reardon DA, Wick W, Gorlia T, Weller M.
Associations of anticoagulant use with outcome in newly diagnosed glioblastoma.
Eur J Cancer. 2018 Jul 20, 2018;101:95-104. doi: 10.1016/j.ejca.2018.06.029. PMID: 30036741. Observational study. ˍ

Remke M, Ramaswamy V.
Infant medulloblastoma - learning new lessons from old strata.
Nat Rev Clin Oncol. 2018 Jul 20, 2018;15(11):659-660. doi: 10.1038/s41571-018-0071-6. PMID: 30030473. Comment. ˍ
Refers to: Robinson GW et al, Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial. Lancet Oncol. 2018 May 16, 2018;19(6):768-784. doi: 10.1016/S1470-2045(18)30204-3. PMID: 29778738. Interventional study. ˍ

Yusuf MB, Gaskins J, Amsbaugh MJ, Woo S, Burton E.
Survival impact of prolonged postoperative radiation therapy for patients with glioblastoma treated with combined-modality therapy.
Neurooncol Pract. 2018 Jul 20, 2019;6(2):112-123. doi: 10.1093/nop/npy027. PMID: 31386043. Observational study. ˍ


Xie JC, Yang S, Liu XY, Zhao YX.
Marital status is associated with survival of patients with astrocytoma.
J Clin Neurosci. 2018 Jul 21, 2018;56:79-87. doi: 10.1016/j.jocn.2018.07.005. PMID: 30041897. Observational study. ˍ

Taiwo R, Mahlokozera T, Kim AH.
Stem nourished by branches: glioblastomas co-opt classic neurotrophic factor signaling to maintain stem-like cell pool.
Stem Cell Investig. 2018 Jul 23, 2018;5:22
. doi: 10.21037/sci.2018.07.01. PMID: 30148155. Editorial. ˍ
Refers to: Wang X et al, Reciprocal Signaling between Glioblastoma Stem Cells and Differentiated Tumor Cells Promotes Malignant Progression. Cell Stem Cell. 2018 Apr 5, 2018;22(4):514-528.e5. doi: 10.1016/j.stem.2018.03.011. PMID: 29625067. Laboratory investigation. ˍ


Gits HC, Anderson M, Stallard S, Pratt D, Zon B, Howell C, Kumar-Sinha C, Vats P, Kasaian K, Polan D, Matuszak M, Spratt DE, Leonard M, Qin T, Zhao L, Leach J, Chaney B, Escorza NY, Hendershot J, Jones B, Fuller C, Leary S, Bartels U, Bouffet E, Yock TI, Robertson P, Mody R, Venneti S, Chinnaiyan AM, Fouladi M, Gottardo NG, Koschmann C.
Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry.
Acta Neuropathol Commun. 2018 Jul 26, 2018;6(1):67. doi: 10.1186/s40478-018-0570-9. PMID: 30049282. Observational study. ˍ

Lundar T, Due-Tønnessen BJ, Fric R, Due-Tønnessen P.
Postoperative radiotherapy for pediatric brain tumor: a lesson learned from treatment of a 5-year-old girl for posterior fossa astrocytoma (WHO1) in 1967.
Acta Neurochir (Wien). 2018 Jul 26, 2018;160(10):2065-2066. doi: 10.1007/s00701-018-3636-3. PMID: 30046877. Letter to the Editor ˍ

Rabadán AT, Hernández D.
[Relevance of histopathological diagnosis in the treatment of brainstem lesions in adults].
Medicina (B Aires). 2018 [Jul 26], 2018;78(5):305-310. PMID: 30285922. Spanish. Observational study. ˍ